BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15387438)

  • 1. A recombinant cell bioassay for measurement of overall estrogenic activity of serum: preliminary results in women with breast cancer.
    Séronie-Vivien S; Dalenc F; Balaguer P; Nicolas JC; Roché H; Faye JC
    Clin Chem Lab Med; 2004; 42(8):889-95. PubMed ID: 15387438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line.
    Legler J; van den Brink CE; Brouwer A; Murk AJ; van der Saag PT; Vethaak AD; van der Burg B
    Toxicol Sci; 1999 Mar; 48(1):55-66. PubMed ID: 10330684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
    Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
    Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new recombinant cell bioassay for ultrasensitive determination of serum estrogenic bioactivity in children.
    Paris F; Servant N; Térouanne B; Balaguer P; Nicolas JC; Sultan C
    J Clin Endocrinol Metab; 2002 Feb; 87(2):791-7. PubMed ID: 11836323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD; Greene GL; Katzenellenbogen BS
    Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
    Wilson VS; Bobseine K; Gray LE
    Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant cell ultrasensitive bioassay for measurement of estrogens in postmenopausal women.
    Wang S; Paris F; Sultan CS; Song RX; Demers LM; Sundaram B; Settlage J; Ohorodnik S; Santen RJ
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1407-13. PubMed ID: 15572429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant cell bioassays for endocrine disruptors: development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals.
    Rogers JM; Denison MS
    In Vitr Mol Toxicol; 2000; 13(1):67-82. PubMed ID: 10900408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitellogenin synthesis in cultured hepatocytes; an in vitro test for the estrogenic potency of chemicals.
    Pelissero C; Flouriot G; Foucher JL; Bennetau B; Dunoguès J; Le Gac F; Sumpter JP
    J Steroid Biochem Mol Biol; 1993 Mar; 44(3):263-72. PubMed ID: 8461258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of estrogenic potency in wastewater and surface water with three in vitro bioassays.
    Murk AJ; Legler J; van Lipzig MM; Meerman JH; Belfroid AC; Spenkelink A; van der Burg B; Rijs GB; Vethaak D
    Environ Toxicol Chem; 2002 Jan; 21(1):16-23. PubMed ID: 11808534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample preparation method for the ER-CALUX bioassay screening of (xeno-)estrogenic activity in sediment extracts.
    Houtman CJ; Leonards PE; Kapiteijn W; Bakker JF; Brouwer A; Lamoree MH; Legler J; Klamer HJ
    Sci Total Environ; 2007 Nov; 386(1-3):134-44. PubMed ID: 17617444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of estrogenic activity in sediments from Haihe and Dagu River, China.
    Song M; Xu Y; Jiang Q; Lam PK; O'Toole DK; Giesy JP; Jiang G
    Environ Int; 2006 Jul; 32(5):676-81. PubMed ID: 16624408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-ras dependent estrogenic effects of epidermal growth factor in the estrogen-independent breast cancer cell line MDA-MB-231.
    Treeck O; Weber A; Boester M; Porz S; Frey N; Diedrich K; Ortmann O
    Breast Cancer Res Treat; 2003 Jul; 80(2):155-62. PubMed ID: 12908818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen.
    Boyan BD; Sylvia VL; Frambach T; Lohmann CH; Dietl J; Dean DD; Schwartz Z
    Endocrinology; 2003 May; 144(5):1812-24. PubMed ID: 12697687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
    Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
    Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive bioassay for detection of dietary estrogens in animal feeds.
    Welshons WV; Rottinghaus GE; Nonneman DJ; Dolan-Timpe M; Ross PF
    J Vet Diagn Invest; 1990 Oct; 2(4):268-73. PubMed ID: 2151311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response to phytoestrogens in endocrine sensitive and resistant breast cancer cells in vitro.
    Limer JL; Parkes AT; Speirs V
    Int J Cancer; 2006 Aug; 119(3):515-21. PubMed ID: 16506217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a fish reporter gene system for the assessment of estrogenic compounds and sewage treatment plant effluents.
    Ackermann GE; Brombacher E; Fent K
    Environ Toxicol Chem; 2002 Sep; 21(9):1864-75. PubMed ID: 12206426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogenic activity in white and red wine extracts.
    Klinge CM; Risinger KE; Watts MB; Beck V; Eder R; Jungbauer A
    J Agric Food Chem; 2003 Mar; 51(7):1850-7. PubMed ID: 12643641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells.
    Zheng ZY; Zheng SM; Bay BH; Aw SE; C-L Lin V
    Breast Cancer Res Treat; 2008 Jul; 110(1):111-25. PubMed ID: 17687644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.